Littérature scientifique sur le sujet « Neisseri meningitidis serogroup B »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Neisseri meningitidis serogroup B ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Neisseri meningitidis serogroup B"
Kepenekli Kadayifci, Eda, Deniz Güneşer Merdan, Ahmet Soysal, Ayşe Karaaslan, Serkan Atıcı, Rıza Durmaz, Perran Boran, İhsan Turan, Güner Söyletir et Mustafa Bakır. « Prevalence of Neisseria meningitidis carriage : a small-scale survey in Istanbul, Turkey ». Journal of Infection in Developing Countries 10, no 04 (28 avril 2016) : 413–17. http://dx.doi.org/10.3855/jidc.7483.
Texte intégralHILSE, R., J. STOEVESANDT, D. A. CAUGANT, H. CLAUS, M. FROSCH et U. VOGEL. « Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis ». Epidemiology and Infection 124, no 2 (avril 2000) : 337–40. http://dx.doi.org/10.1017/s0950268899003647.
Texte intégralKourna Hama, Mamadou, Dam Khan, Boubou Laouali, Catherine Okoi, Abdoulaye Yam, Moussa Haladou, Archibald Worwui et al. « Pediatric Bacterial Meningitis Surveillance in Niger : Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction ». Clinical Infectious Diseases 69, Supplement_2 (5 septembre 2019) : S133—S139. http://dx.doi.org/10.1093/cid/ciz598.
Texte intégralWang, Quan, Zhujun Shao, Xiaoting Wang, Yuan Gao, Machao Li, Li Xu, Jianguo Xu et Lei Wang. « Genetic Study of Capsular Switching between Neisseria meningitidis Sequence Type 7 Serogroup A and C Strains ». Infection and Immunity 78, no 9 (12 juillet 2010) : 3883–88. http://dx.doi.org/10.1128/iai.00363-10.
Texte intégralAbady, N. R., C. J. D. Guglielmino, R. M. Graham, J. Adelskov, H. V. Smith, B. K. C. Patel et A. V. Jennison. « Genetic characterization of a Neisseria meningitidis cluster in Queensland, Australia ». Canadian Journal of Microbiology 63, no 7 (juillet 2017) : 644–47. http://dx.doi.org/10.1139/cjm-2017-0017.
Texte intégralLi, Yanwen, Yao-hui Sun, Cathy Ison, Myron M. Levine et Christoph M. Tang. « Vaccination with Attenuated Neisseria meningitidis Strains Protects against Challenge with Live Meningococci ». Infection and Immunity 72, no 1 (janvier 2004) : 345–51. http://dx.doi.org/10.1128/iai.72.1.345-351.2004.
Texte intégralStabler, Richard A., Gemma L. Marsden, Adam A. Witney, Yanwen Li, Stephen D. Bentley, Christoph M. Tang et Jason Hinds. « Identification of pathogen-specific genes through microarray analysis of pathogenic and commensal Neisseria species ». Microbiology 151, no 9 (1 septembre 2005) : 2907–22. http://dx.doi.org/10.1099/mic.0.28099-0.
Texte intégralPortilho, Amanda Izeli, Gabriela Trzewikoswki de Lima et Elizabeth De Gaspari. « Neisseria meningitidis : analysis of pili and LPS in emerging Brazilian strains ». Therapeutic Advances in Vaccines and Immunotherapy 8 (janvier 2020) : 251513552091919. http://dx.doi.org/10.1177/2515135520919195.
Texte intégralCeyhan, Mehmet, Yasemin Ozsurekci, Cihangül Bayhan, Nezahat Gurler, Enes Sali, Melike Keser Emiroglu, Fatma Nur Öz et al. « 682. The Changing Epidemiology of Bacterial Meningitis During 2015–2017 in Turkey : A Hospital-Based Prospective Surveillance Study ». Open Forum Infectious Diseases 5, suppl_1 (novembre 2018) : S246. http://dx.doi.org/10.1093/ofid/ofy210.689.
Texte intégralCaesar, Nicole M., Kenneth A. Myers et Xin Fan. « Neisseria meningitidis serogroup B vaccine development ». Microbial Pathogenesis 57 (avril 2013) : 33–40. http://dx.doi.org/10.1016/j.micpath.2013.02.003.
Texte intégralThèses sur le sujet "Neisseri meningitidis serogroup B"
Horton, Rachel. « The mucosal immune response to Neisseria meningitidis serogroup B ». Thesis, University of Bristol, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424640.
Texte intégralLucidarme, Jay. « Potential coverage of an investigational, multi-component, meningococcal vaccine with a focus on the ST-269 clonal complex ». Thesis, University of Manchester, 2012. https://www.research.manchester.ac.uk/portal/en/theses/potential-coverage-of-an-investigational-multicomponent-meningococcal-vaccine-with-a-focus-on-the-st269-clonal-complex(a686ee75-58c8-4e86-9f23-1342ca750696).html.
Texte intégralDutta, Ray Tathagat. « Novel Complement Blocking Antibodies Against Serogroup B N. meningitidis : A Dissertation ». eScholarship@UMMS, 2010. https://escholarship.umassmed.edu/gsbs_diss/495.
Texte intégralLövkvist, Lena. « Receptor interactions between pathogenic bacteria and host cells / ». Uppsala : Acta Universitatis Upsaliensis : Uppsala universitetsbibliotek [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7782.
Texte intégralSadarangani, Manish. « Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system ». Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:1c137f32-a37d-4cd4-bac0-4c0a927564bd.
Texte intégralTERRANOVA, LEONARDO. « NEISSERIA MENINGITIDIS SEROGROUP B CARRIAGE BY ADOLESCENTS AND YOUNG ADULTS LIVING IN MILAN, ITALY : GENETIC CHARACTERISTICS AND POTENTIAL CORRELATION WITH PRESENTLY AVAILABLE MENB VACCINE ». Doctoral thesis, Università degli Studi di Milano, 2019. http://hdl.handle.net/2434/612011.
Texte intégralNDONI, ENEA. « Characterization of the immune response and cross protection activity elicited by the Neisserial Heparin Binding Antigen (NHBA), a component of the 4CMenB vaccine ». Doctoral thesis, Università di Siena, 2017. http://hdl.handle.net/11365/1011542.
Texte intégralMoodley, Chivonne. « Molecular characterisation of Neisseria meningitidis serogroup B isolates in South Africa, 2002- 2006 ». Thesis, 2011. http://hdl.handle.net/10539/10562.
Texte intégralDespite being a fulminant pathogen, Neisseria meningitidis (meningococcus) is part of the commensal flora of the human nasopharynx. Globally, five meningococcal serogroups (A, B, C, Y and W135) cause the majority of invasive disease. Most serogroup B cases occur sporadically but may be endemic or epidemic within a geographic region. In South Africa, there are limited data on invasive serogroup B clones and the antigenic diversity of certain meningococcal outer membrane proteins. This study examined the molecular epidemiology of serogroup B meningococci in South Africa from 2002 through 2006. Invasive meningococcal isolates were submitted to a national laboratory-based surveillance system. For this study, serogroup B isolates were characterised by pulsed-field gel electrophoresis (PFGE), PorA, FetA and multilocus sequence (MLST) typing. PorA, FetA and multilocus sequence (MLST) typing were performed on all 2005 isolates (n=58) and randomly selected isolates from other years (n=25). A total of 2144 invasive cases were reported over the study period. Of these, 76% (1627/2144) had viable isolates available for serogrouping and 307 (19%) were serogroup B. Serogroup B cases were reported from across the country however the majority were from the Western Cape province. The highest incidence of serogroup B was in children less than 5 years of age. Isolates displayed a high level of diversity by PFGE. Despite this diversity the majority of serogroup B meningococci collected over the 5-year period could be grouped into several clonal clusters representative of global invasive MLST clonal complexes. Overall, the most predominant MLST clones in South Africa were ST-32/ET-5 and ST-41/44/lineage 3. In addition, at least 19 PorA types and 16 FetA types were determined among selected isolates. Globally invasive serogroup B disease is caused by heterogeneous strains however, prolonged outbreaks in several countries have been due to strains of the ST-32/ET-5 and ST-41/44/lineage 3 clonal complexes. At present, serogroup B disease in South Africa is not dominated by an epidemic clone, however, global clonal complexes ST-32/ET-5 and ST-41/44/lineage 3 are circulating in Western Cape and Gauteng, respectively.
Hsu, Chi-An, et 許至安. « Preparation and characterization of monoclonal antibody to serogroup B Neisseria meningitides ». Thesis, 2003. http://ndltd.ncl.edu.tw/handle/45700099563466034329.
Texte intégral國立中興大學
分子生物學研究所
91
Abstract Neisseria meningitidis is a Gram-negative, encapsulated bacterium that has been classified into five major pathogenic serogroups (A, B, C, Y,and W-135) on the basis of the chemical composition of distinctive capsular polysaccharides. N. Meningitidis is a major cause of sepsis and meningitis. At present, polysaccharide vaccines are available for prevention of disease caused by serogroup A, C, Y,and W-135 strains. There is no promising vaccine to prevent N. meningitidis serogroup B (GBM). Because the capsular polysaccharide of serogroup B is composed of a homolinear polymer α(2-8)N-acetyl(N-Ac)3 neuraminic acid (polysialic acid),which is similar to NCAM of human neural cell, using serogroup B polysaccharide as vaccine will possibly result in autoimmunity. In this study, I prepared monoclonal antibodies to be used for identifying vaccine candidates from mice immunized with heat-killed GBM. To identify mAbs against GBM which do not cross-react to human cells, the binding of mAbs to GBM and to the human neuroblastoma cell IMR-32 was determined by ELISA. The bactericidal activity of the mAbs was then examined by complement-mediated bacteriolysis assay. Currently, I have obtained two mAbs 4-7-3 and 4-13-227 with the desired properties. To gain some information about the antigens of these two mAbs, Western blot analysis was carried out. While no immunoreactive band was observed in the blot probed with 4-13-227, a band at position 10~15 kDa was detected by mAb 4-7-3. These results indicated that mAb 4-13-227 may recognize a non-protein antigen, while the Ag for 4-7-3 is a protein. Since it is difficult to study a non-protein antigen, this study is focused on the characterization of mAb 4-7-3. By performing affinity selection of phage display random peptide libraries against mAb 4-7-3 followed by immunoscreening, seven phage clones were identified. Sequence analysis of these seven clones revealed three different peptides. The binding of these peptides displayed on phage particle was confirmed by inhibition ELISA. To determine the identity of the Ag for 4-7-3, total protein of GBM was separated by 2D-electrophoresis, identified by probing with mAb 4-7-3 and subjected to MULDI-TOF analysis. The result indicated that the antigen for 4-7-3 is NMB1468 which was annotated as a hypothetic protein for the genome sequence of the N. meningitidis MC58. The data that mAbs 4-7-3 can mediate complement bacteriolysis indicated that this protein is a surface antigen. The possibility of using NMB1468 protein as a vaccine for N. meningitidis is under investigation.
Livres sur le sujet "Neisseri meningitidis serogroup B"
Nadel, Simon, et Johnny Canlas. Management of meningitis and encephalitis in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0241.
Texte intégralChapitres de livres sur le sujet "Neisseri meningitidis serogroup B"
Caugant, D. A., L. O. Frøholm, C. T. Sacchi et R. K. Selander. « Genetic structure and epidemiology of serogroup B Neisseria meningitidis ». Dans Neisseriae 1990, sous la direction de Mark Achtman, Peter Kohl, Christian Marchal, Giovanna Morelli, Andrea Seiler et Burghard Thiesen, 37–42. Berlin, Boston : De Gruyter, 1991. http://dx.doi.org/10.1515/9783110867787-008.
Texte intégralV. G., Sierra G., Campa H. C., Garcia I. L., Sotolongo P. F., Izquierdo P. L., Valcarel N. M., Casanueva G. V. et al. « Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC® against disease caused by serogroup B Neisseria meningitidis ». Dans Neisseriae 1990, sous la direction de Mark Achtman, Peter Kohl, Christian Marchal, Giovanna Morelli, Andrea Seiler et Burghard Thiesen, 129–34. Berlin, Boston : De Gruyter, 1991. http://dx.doi.org/10.1515/9783110867787-025.
Texte intégralGreen, Luke R., Joseph Eiden, Li Hao, Tom Jones, John Perez, Lisa K. McNeil, Kathrin U. Jansen et Annaliesa S. Anderson. « Approach to the Discovery, Development, and Evaluation of a Novel Neisseria meningitidis Serogroup B Vaccine ». Dans Vaccine Design, 445–69. New York, NY : Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3387-7_25.
Texte intégralGriffiss, J. McLeod, et Janice J. Kim. « Antigenic specificity of natural bactericidal activity for serogroup B and C strains of Neisseria meningitidis in human sera ». Dans Gonococci and Meningococci, 523–27. Dordrecht : Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-009-1383-7_82.
Texte intégralDelvig, A. A., L. I. Krasnoproshina, V. I. Kuvakina et B. A. Dmitriev. « Protective activity of detoxified lipooligosaccharides of Neisseria meningitidis serogroups A and B in mice ». Dans Neisseriae 1990, sous la direction de Mark Achtman, Peter Kohl, Christian Marchal, Giovanna Morelli, Andrea Seiler et Burghard Thiesen, 331–36. Berlin, Boston : De Gruyter, 1991. http://dx.doi.org/10.1515/9783110867787-060.
Texte intégral« The Postlicensure Impact of Haemophilus Influenzae Type b and Serogroup C Neisseria Meningitidis Conjugate Vaccines ». Dans New Generation Vaccines, 864–95. CRC Press, 2004. http://dx.doi.org/10.1201/9781439834404-43.
Texte intégralMiller, Elizabeth, Helen Campbell et Mary Ramsay. « Post-Licensure Impact of Haemophilus influenzae Type b and Serogroup C Neisseria meningitidis Conjugate Vaccines in Industrialized Countries ». Dans New Generation Vaccines, Fourth Edition, 452–63. CRC Press, 2009. http://dx.doi.org/10.3109/9781420060744-44.
Texte intégralBrandtzaeg, Petter. « Meningococcal infections ». Dans Oxford Textbook of Medicine, 709–22. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199204854.003.070605_update_004.
Texte intégralBrandtzaeg, Petter. « Meningococcal infections ». Dans Oxford Textbook of Medicine, sous la direction de Christopher P. Conlon, 1010–25. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0109.
Texte intégralActes de conférences sur le sujet "Neisseri meningitidis serogroup B"
Corrêa, Marilza, Maria Leal, Elza Scott, Adenilza Bello, Eduardo Duarte et Ellen Jessouroun. « Characterization of oligosaccharide of Neisseria meningitidis Serogroup B ». Dans III Seminário Anual Científico e Tecnológico de Bio-Manguinhos. Instituto de Tecnologia em Imunobiológicos, 2015. http://dx.doi.org/10.35259/isi.sact.2015_28536.
Texte intégralCorrêa, Marilza, Maria Leal, Elza Scott, Adenilza Bello, Eduardo Duarte et Ellen Jessouroun. « Characterization of native and deacylated Lipid A from lipooligosaccharide of Neisseria meningitidis Serogroup B ». Dans III Seminário Anual Científico e Tecnológico de Bio-Manguinhos. Instituto de Tecnologia em Imunobiológicos, 2015. http://dx.doi.org/10.35259/isi.sact.2015_28598.
Texte intégralSilva, Taís Lorrane Mendes, Júlia Maria Orsini Zava, Bruna Chociai dos Santos et Helenton Cristhian Barrena. « Hospitalizations for meningococcal infection in the southern region of Brazil : epidemiologic characterizations and prevalent serotypes ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.361.
Texte intégral